AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials

Scroll

Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”

Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.

United States of America

Bias: lean left

0/500

Note: Comments are moderated. Please keep it civil. Max 3 comments per day.

No recent articles found in this language.